ClinicalTrials.Veeva

Menu

Radical Hysterectomy: Evolution Of Surgical Approach and Related Outcomes (RESurg)

V

Vall d'Hebron University Hospital (HUVH)

Status

Completed

Conditions

Surgery--Complications

Treatments

Procedure: Open radical hysterectomy
Procedure: Robotically assisted radical hysterectomy
Procedure: laparoscopic radical hysterectomy

Study type

Observational

Funder types

Other

Identifiers

NCT03577613
PR(AMI)23/1999

Details and patient eligibility

About

Prospective controlled study (Canadian Task Force II-2) : Comparison analysis regarding surgical outcomes, complications, overall survival (OS), disease free survival (DFS) and cancer specific survival between patients subjected to radical Hysterectomy either by open radical hysterectomy (ORH) or minimally invasive surgery (MIS): laparoscopic (LRH) or robotically assisted radical hysterectomy (RRH).

Full description

Study Objective: To analyse the effect that the introduction of minimally invasive procedures has had on surgical and oncological outcomes when compared with conventional open radical hysterectomy (ORH) in a national reference cancer center Design: A prospective controlled study (Canadian Task Force II-2) Setting: A university teaching hospital Patients: All patients that underwent RH as primary treatment for cervical cancer in our institution between May 1999 and June 2016, with a total of 188 patients.

Interventions: Patients underwent an open radical hysterectomy (ORH) or minimally invasive surgery (MIS): laparoscopic (LRH) or robotically assisted radical hysterectomy (RRH).

Enrollment

188 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer.
  • Subjected to Radical Hysterectomy.

Exclusion criteria

  • Pregnant women in which a RH was performed at the time of caesarean section.
  • Previous chemotherapy treatment
  • Previous pelvic radiotherapy

Trial design

188 participants in 3 patient groups

Early stage Cervical Cancer- Open Radical Hysterectomy(RH)
Description:
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a open RH at our institution as primary treatment were included in the study
Treatment:
Procedure: Open radical hysterectomy
Early stage Cervical Cancer- Laparoscopic Radical Hysterectomy
Description:
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a laparoscopic RH at our institution as primary treatment were included in the study
Treatment:
Procedure: laparoscopic radical hysterectomy
Early stage Cervical Cancer- Robotic radical Hysterectomy(RRH)
Description:
Patients who were clinically diagnosed with FIGO stage IA2-IB1-IIA1 cervical cancer and underwent a robotically assisted RH at our institution as primary treatment were included in the study
Treatment:
Procedure: Robotically assisted radical hysterectomy

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems